ArticleBiophysics reports2026
Stem cell-derived exosomes preserve diabetic islet function: a systematic review and meta-analysis of preclinical studies.
Article in Biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes remains an incurable disease, and emerging evidence suggests that exosomes may offer promising therapeutic potential for both diabetes and its complications. However, their specific effects on pancreatic islet function are still under investigation. This meta-analysis aimed to evaluate the efficacy of stem cell-derived exosomes (SC-Exs) in preserving islet function in diabetes. A comprehensive search of PubMed, Embase, Cochrane Library, and Web of Science databases was conducted from inception to May 1, 2025, to identify studies assessing the impact of SC-Exs on islet function in diabetic models. Data on insulin levels, islet quantity, and inflammatory markers were extracted and analyzed using Stata 14.0 and Review Manager (RevMan) 5 software. Ten eligible studies were included in the meta-analysis. Compared with controls, SC-Exs significantly increased insulin levels (SMD = 10.09, 95% CI: 7.97-12.21,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.